Fig. 2From: Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PETReceiver operating characteristic (ROC) curve analysis for the early identification of patients with non-complete responseBack to article page